PTJ
EXAS

Paul Tudor Jones’s Exact Sciences EXAS Stock Holding History

Paul Tudor Jones’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,200
Closed -$528K – 3815
2025
Q4 		$528K Buy
5,200
+300
+6% +$24.1K ﹤0.01% 2703
2025
Q3 		$268K Sell
4,900
-100
-2% -$5K ﹤0.01% 3046
2025
Q2 		$266K Sell
5,000
-1,600
-24% -$81.3K ﹤0.01% 2956
2025
Q1 		$286K Buy
6,600
+2,800
+74% +$142K ﹤0.01% 2624
2024
Q4 		$214K Buy
+3,800
New +$236K ﹤0.01% 2798

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Paul Tudor Jones's EXAS Position: Q1 2026 in Review

Paul Tudor Jones sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,978,628 shares — an estimated $201M sold.

Paul Tudor Jones first reported a position in EXAS in Q1 2014 and held it in 23 quarters. The position peaked at $201M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Paul Tudor Jones reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 1,978,628 Exact Sciences shares in Q1 2026, an estimated $201M.
  • Paul Tudor Jones first reported a position in Exact Sciences in Q1 2014 and held it in 23 quarters.
  • Paul Tudor Jones's Exact Sciences position peaked at $201M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.